- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA Clears Update of AI-Enabled Imaging Contour Models
Updates to Contour ProtegeAI 4.0 reportedly include enhanced algorithms for radiation oncology segmentation and molecular radiotherapy.
The Food and Drug Administration (FDA) has granted 510(k) clearance for the updated version of Contour ProtegeAI® 4.0 (MIM Software), a platform that provides automated deep learning segmentation for organs at risk (OARs).
Contour ProtegeAI 4.0 offers improved algorithms for radiation oncology as well as improvements for molecular radiotherapy, according to MIM Software.
“Over the past several months, the MIM Software team has worked hard to focus this new version on improving our contouring performance,” noted Jay Obman, a product manager at MIM Software, Inc. “The initial testing has shown a good improvement in our overall contour quality, and I’m excited for our users to reap the benefits of those improvements as well as some new contours we’ve added.”
The company adds that the software facilitates standardized, efficient workflows and provides automated preparation for physician target volume (PTV) contouring. Contour ProtegeAI 4.0 also integrates with Eclipse™, RayStation®, Monaco® and Pinnacle, according to MIM Software.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
